Substituted 1,3,5-triazines as inhibitors for a rho family of GTP-ases

The present invention relates to compounds of Formula (I) or pharmaceutically acceptable salts or solvates thereof:It further discloses a pharmaceutical composition comprising the compounds of Formula (I) and their uses, in particular in the treatment of diseases or disorders associated to increased...

Full description

Saved in:
Bibliographic Details
Main Authors De Vivo, Marco, Ortega Martinez, Jose Antonio, Ganesan, Anand, Jahid, Sohail
Format Patent
LanguageEnglish
Published 09.04.2024
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to compounds of Formula (I) or pharmaceutically acceptable salts or solvates thereof:It further discloses a pharmaceutical composition comprising the compounds of Formula (I) and their uses, in particular in the treatment of diseases or disorders associated to increased relative to physiological or desired RhoJ/Cdc42 levels of expression or function.
Bibliography:Application Number: US202117456346